Exercise is associated with many beneficial metabolic and health effects. Today it is known that during exercise, cytokines and other peptides are secreted by the working muscles with the potential to act locally within the muscle tissue or in an endocrine manner by targeting distant organs. Although they are not exclusively secreted by the muscle cells, such proteins are classified as "myokines" within the context of skeletal muscle physiology.[@R1] Emerging evidence suggests that these muscle-derived cytokines play an important role in mediating both acute exercise-associated metabolic changes, as well as the metabolic changes following training adaptation.[@R2] Increased insulin responsiveness, glucose uptake and fatty acid oxidation within skeletal muscles are some of the anticipated beneficial effects of regular exercise, all of which have been shown in part to be mediated by myokines. Likewise, systemic effects of myokines released in response to muscle contractions are involved in various immediate and long-term metabolic regulatory mechanisms in distant organs like the adipose tissue.[@R3] Thus myokines are central to our understanding of the cross talk during and after exercise between skeletal muscles and other organs ([Fig. 1](#F1){ref-type="fig"}). In view of that, further insight into the effect and regulation of potential myokines is of major importance.

![**Figure 1.** Muscle-organ cross talk mediated by myokines. In response to muscle contraction skeletal muscle expresses and releases myokines into the circulation. The myokines mediate effects locally within the muscle in an autocrine or paracrine manner to increase glucose uptake and fat oxidation. When released into the circulation, the myokines act in a hormone-like fashion mediating peripheral effects including increased hepatic glucose production during exercise, lipolysis in adipose tissue and likely have a preventing effect on tumor growth.](adip-1-164-g1){#F1}

The first myokine identified was interleukin 6 (IL-6),[@R4] which is now recognized as the prototype myokine, exerting both local muscular effects as well as endocrine effects on distant organs.[@R5] Since the discovery of IL-6, it has been recognized that skeletal muscle has the capacity to express a large range of myokines. Today the list of verified myokines includes IL-6, IL-8, IL-15, brain-derived neurotrophic factor (BDNF), leukemia inhibitory factor (LIF), fibroblast growth factor 21 (FGF21) and follistatin-like-1.[@R3] In addition, recent proteomic studies have predicted that the list of myokines may include more than 600 candidates belonging to distinctly different protein families.[@R6] Recently we and others reported that an acute bout of exercise in mice induced a 6-fold increase in skeletal muscle mRNA and a 2.4-fold increase in serum concentration of the chemokine CXC motif ligand-1 (CXCL-1) also known as KC (keratinocyte-derived chemokine), suggesting that CXCL-1 acts as an exercise-induced myokine.[@R7]^,^[@R8] Murine CXCL-1 is often mentioned as the functional homolog to human IL-8, which previously was identified as a myokine in humans.[@R9] However, murine CXCL-1 shares the highest sequence homology (90% homology in conserved regions) with human CXCL-1, also named GROα (growth-related oncogene, α).[@R10] CXCL-1 belongs to the glutamate-leucine-arginine (ELR)-containing CXC chemokine family and has primarily received attention for its role in inflammation, chemotaxis and angiogenesis,[@R11]^,^[@R12] its neuro-protective effects[@R13] and as a regulator of tumor growth[@R14]^,^[@R15] whereas its role in metabolism remains to be clarified.

In line with the involvement of myokines in regulation of skeletal muscle metabolism, we went on to characterize the role of CXCL-1 in the exercise-associated adaptations in oxidative capacity in the muscle.[@R16] To this end, we used a mouse model of in vivo electrotransfer-mediated overexpression of CXCL-1 in the tibialis cranialis muscle. The resulting increases in muscle CXCL-1 mRNA and serum CXCL-1 in this model are within the normo-physiological range and comparable to levels observed in response to a single bout of exercise.[@R7]^,^[@R8] Importantly this model reflects the long-term effects of regular exercise-induced peaks in CXCL-1 rather than an occasional acute exercise effect. As assessed by MR scanning, DEXA scanning and weight of dissected organs, this long-term overexpression model revealed a CXCL-1-dependent reduction in the diet-induced fat accumulation in adipose tissue. In fact, after three months of high-fat feeding, CXCL-1 transfected animals had a significantly lower visceral fat mass (1277.5 ± 107.2 mg) compared with control mice (1889.5 ± 147.1 mg, p \< 0.01). Likewise, did these mice have lower subcutaneous fat mass (494.8 ± 51.2 mg) compared with control mice (637.2 ± 40.8 mg, p \< 0.05). Chow-fed mice also had lower levels of adipose tissue. As determined by DEXA scanning eight weeks after the transfection, the CXCL-1 transfected mice had significantly lower proportion of total body fat (13.2 ± 1.6%) compared with chow-fed control mice (19.8 ± 1.5%, p \< 0.01). Similar results were found by MR scanning. Interestingly, the reduced accumulation of fat in the CXCL-1 transfected animals was associated with increased fatty acid oxidation in the muscles, as measured both directly and indirectly through upregulation of rate-limiting oxidative enzymes. Furthermore, the CXCL-1-dependent reduction adipose tissue mass was accompanied by whole-body improvements in glucose tolerance and insulin sensitivity. Clearly this study shows that by influencing metabolism locally in the muscles, the myokines are likely to be involved in the whole-body metabolic adaptive changes that occur in response to regular exercise like, for example, attenuation of fat accumulation.

Induction of other myokines, in particular IL-6, has been involved in similar metabolic adaptations. By signaling through the gp130Rβ/IL-6Rα receptor, causing subsequent activation of the AMPK and/or phosphatidylinositol 3-kinase (PI3-kinase) pathways, IL-6 acts within the muscle to increase glucose uptake and fatty acid oxidation.[@R1] Upon receptor activation, IL-6 signals through either the Janus kinase/signal transducer and activator of transcription (STAT) pathway or a Ras/ERK/CAAT enhancer binding protein (C/EBP) β pathway.[@R17]

In addition to the local muscular effects that indirectly affect whole body metabolism, myokines have also been shown to act directly on distant organs when released into the systemic circulation. Again IL-6 can be used as an example. Following release from both type I and type II muscle fibers in response to muscle contractions circulating IL-6 works in an endocrine fashion.[@R1] In adipose tissue IL-6 has been shown to increase lipolysis and fatty acid oxidation,[@R18] likely through the induction of AMPK phosphorylation.[@R19] In further support of IL-6 affecting accumulation of fat in adipose tissue, IL-6 knockout mice have been found to develop late-onset obesity.[@R20] In the liver, muscle-derived IL-6 is suggested to enhance hepatic glucose production during exercise[@R21] and has been reported to directly upregulate gluconeogenic genes, i.e., phosphoenolpyruvate carboxykinase (PEPCK) and 6-phosphatase (G6Pase), leading to increased hepatic glucose production.[@R22] Interestingly, IL-6 is also thought to affect pancreatic function, and secretory products from skeletal muscles have directly been shown to increase proliferation and glucose-stimulated insulin secretion from primary β-cells.[@R23]^,^[@R24] In addition, injection of IL-6 as well as elevated levels of IL-6 induced by exercise have recently been demonstrated to stimulate GLP-1 secretion from intestinal L cells and pancreatic α cells, leading to improvements in insulin secretion and glycemia.[@R25] Thus, skeletal muscle and the pancreas act in a synergistic manner to monitor systemic glucose homeostasis and these results demonstrate a role of myokines in mediating cross talk between insulin sensitive tissues.

In line with this, plasma IL-6 is not only directly correlated with exercise intensity, but is also inversely related to plasma glucose level.[@R26] With this, it is thought that IL-6 works as a sensor of carbohydrate availability.[@R18]^,^[@R22]^,^[@R27] Thus, contracting muscle fibers produce and release IL-6 in an endocrine manner to facilitate substrate mobilization from liver and adipose tissue. More recently it was also reported that muscle-derived IL-6 induces expression of CXCL-1 in the liver and that IL-6 is directly essential for the peaks in liver CXCL-1 expression that occurs in response to exercise. These observations further suggest that IL-6 is involved in muscle-to-liver cross talk during exercise.[@R8] Also, an exercise-induced and PGC1-a (transcriptional co-activator PPAR-γ co-activator-1 α) dependent myokine named Irisin was recently reported to replicate some of the positive effects of exercise and diet. It increases energy expenditure likely through stimulation of UCP-1 and brown-fat-like development and was found to improve glucose tolerance in obese animals.[@R28]

Definitely the communication network between muscles and other tissues define a physiological concept of muscle-to-organ cross talk. Common for many of the identified myokines are a direct or indirect effect on adipose tissue. Importantly, visceral fat is known as a source of systemic chronic low-grade inflammation, which in turn is involved in the pathogenesis of various disorders like insulin resistance, atherosclerosis and cancer.[@R5] The attenuating effect of myokines on accumulation visceral adipose tissue either by acting directly on the adipose tissue itself or by improving fatty acid metabolism in the muscle is therefore of major importance in describing why inactivity is a strong risk factor for development of various diseases induced by low-grade inflammation like type 2 diabetes and cancer.[@R5] With this, the myokines could in theory be therapeutic for human metabolic disease and other kind of disorders that normally are improved with regular exercise.

In continuation of this, regular exercise is clearly associated with reduced cancer development and progression in large epidemiological studies[@R29]^,^[@R30] and a few animal studies report that exercise is associated with decreased tumor growth and metastatic dissemination.[@R31] The protective effect of exercise is applicable on a diverse array of neoplastic diseases, indicating that the mechanism behind this protection is not limited by specific oncogenic mutations but likely caused by more general mechanisms. We have recently shown that myokines, in addition to the reduction of low-grade inflammation, also play a direct role in the tumor-suppressing effect of exercise. By incubating breast cancer cells with serum taken immediately after an exercise bout, we found that the exercise-conditioned serum could reduce cancer cell viability and induce apoptosis through caspase activation.[@R32] This study identified Oncostatin M as an exercise-induced myokine with anti-proliferative effects on the breast cancer cells. Likely the protection of exercise on tumor development and progression occurs through a variety of exercise-related changes like improved inflammatory fitness, immune function, growth factor signaling, sex hormones and improved metabolic status some of which are affected by the myokines. Knowing the mechanisms behind the beneficial anti-cancer effect of exercise will serve as foundation for public health guide with regard to exercise and likely facilitate the improvement of current anti-cancer strategies

Taken together, with the identified pleiotropic effects of myokines on multiple tissues, leading to fine-tuning of fuel utilization and energy homeostasis in these tissues, we believe that these secreted myokines are able to restore a healthy cellular environment, reduce low-grade inflammation and thereby prevent metabolic related diseases like insulin resistance and cancer.
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